Empire Life Investments Inc. Nektar Therapeutics Transaction History

Empire Life Investments Inc.

$1.58 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$2.03 - $4.28 $2,502 - $5,277	-1,233 Reduced 1.21%	100,945 $228,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $10,849 - $18,344	3,569 Added 3.62%	102,178 $327,000
Q2 2022 Aug 03, 2022	BUY	$3.17 - $6.17 $5,918 - $11,519	1,867 Added 1.93%	98,609 $375,000
Q1 2022 May 11, 2022	BUY	$4.16 - $13.72 $2,067 - $6,818	497 Added 0.52%	96,742 $521,000
Q4 2021 Feb 09, 2022	BUY	$10.83 - $18.41 $2,415 - $4,105	223 Added 0.23%	96,245 $1.3 Million
Q3 2021 Nov 09, 2021	BUY	$13.07 - $18.84 $4,509 - $6,499	345 Added 0.36%	96,022 $1.73 Million
Q2 2021 Aug 04, 2021	BUY	$16.52 - $20.4 $25,011 - $30,885	1,514 Added 1.61%	95,677 $1.64 Million
Q1 2021 Apr 29, 2021	SELL	$16.56 - $25.46 $33,186 - $51,021	-2,004 Reduced 2.08%	94,163 $1.88 Million
Q4 2020 Feb 09, 2021	SELL	$15.77 - $19.03 $7,869 - $9,495	-499 Reduced 0.52%	96,167 $1.64 Million
Q3 2020 Nov 05, 2020	BUY	$16.59 - $24.79 $5,043 - $7,536	304 Added 0.32%	96,666 $1.6 Million
Q2 2020 Aug 03, 2020	SELL	$16.86 - $23.44 $107,819 - $149,898	-6,395 Reduced 6.22%	96,362 $2.23 Million
Q1 2020 Apr 23, 2020	BUY	$14.47 - $27.96 $23,065 - $44,568	1,594 Added 1.58%	102,757 $1.83 Million
Q4 2019 Jan 21, 2020	BUY	$15.87 - $23.12 $8,046 - $11,721	507 Added 0.5%	101,163 $2.18 Million
Q3 2019 Oct 25, 2019	BUY	$16.91 - $36.27 $99,210 - $212,796	5,867 Added 6.19%	100,656 $1.83 Million
Q2 2019 Aug 20, 2019	BUY	$31.0 - $36.3 $42,005 - $49,186	1,355 Added 1.45%	94,789 $3.37 Million
Q1 2019 Apr 17, 2019	BUY	$31.58 - $46.35 $1.18 Million - $1.73 Million	37,377 Added 66.68%	93,434 $3.14 Million
Q4 2018 Feb 04, 2019	BUY	$30.43 - $56.65 $23,613 - $43,960	776 Added 1.4%	56,057 $1.84 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $16,911 - $24,930	-364 Reduced 0.65%	55,281 $3.37 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $2.57 Million - $5.81 Million	55,645 New	55,645 $2.72 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.

Account